Betta Pharmaceuticals Co., Ltd. (300558.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap19.53B
Enterprise Value20.63B
P/E Ratio45.38
PEG Ratio0.99
Price/Sales Ratio5.55
Price/Book Ratio3.21
Enterprise/Revenue6.06
Enterprise/EBITDA22.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.12
Operating Margin0.15
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue3.61B
Revenue/Share9.16
Gross Profit2.87B
EBITDA1.04B
Net Income305.33M
Diluted EPS0.73

Balance Sheet

Total Cash455.75M
Total Cash/Share1.08
Total Debt2.43B
Total Debt/Equity0.37
Current Ratio0.85
Book Value Per Share15.77

Price History

52-Week Change-26.33
52-Week High78.18
52-Week Low40.1
Moving Average 50 Days54.21
Moving Average 200 Days50.93

Statistics

Average Volume17.34M
Shares Outstanding423.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield0.3
Payout Ratio0.07
Last Split FactorN/A
Last Split DateN/A
AD